http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08508498-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-75 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-405 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-75 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 1994-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1996-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H08508498-A |
| titleOfInvention | Cyclic compounds useful as inhibitors of platelet glycoprotein IIb / IIIa |
| abstract | (57) [Summary]nThe present invention comprises novel cyclic compounds containing a carbocyclic ring system useful as antagonists of the platelet glycoprotein IIb / IIIa complex, such cyclic compounds with or without other therapeutic agents. Pharmaceutical compositions, and cyclic compounds thereof with or without other therapeutic agents, as thrombolytic agents and / or for treating other thromboembolic disorders to inhibit platelet aggregation. Is about how to use. The present invention also provides an anticoagulant, such as warfarin or heparin, or an antiplatelet agent, such as aspirin, piroxicam or ticlopyridine, or a thrombin inhibitor, such as a boropeptide, hirudin or argatroban, for treating thromboembolic disorders. , Or a thrombolytic agent, such as a tissue plasminogen activator, anistreplase, urokinase or streptokinase or a combination thereof in combination with a cyclic compound of the invention. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013510863-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2001506603-A |
| priorityDate | 1993-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 579.